Patent · US Active

Antibodies to VLA-1

US8084028B2 · kind B2 · utility

6Cited by
27References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 31, 2011
Grant dateDec 27, 2011
Priority date
Expiry dateJan 31, 2031

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A90/10
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Antibodies that specifically bind to VLA-1 integrin and methods of using these antibodies to treat immunological disorders in a subject. Also included are crystal structures of complexes formed by VLA-1 antibodies and their ligands, and VLA-1 antagonists and agonists identified by using the structure coordinates of these structures.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.